US$ 21.65
glp-1 and cancer treatment Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential Underlying Molecular Pathways GLP-1 Receptor Agonists as Treatments
Description
The jury is still out on the long-term effects and results of GLP-1s, but early signs indicate stabilization for diabetic members with respect to cost and clinical outcomes

They are widely used for weight management and type 2 diabetes

The new Wegovy pill starts at $149/month for the lowest dose (1.5 mg), increasing to $199/month for the 4 mg dose and $299/month for the higher 9 mg and 25 mg doses
If you are interested in weight loss support you can start a consultation here

Cost considerations for microdosing protocols Cost is a practical factor that affects whether microdosing is feasible for your situation
